Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Sunpeaks Ventures, Inc. (OTCBB: SNPK) Featured By Small Cap Investment Research

(EMAILWIRE.COM, April 11, 2012 ) Los Angeles, CA -- Small Cap Investment Research (SmallCapInvestmentResearch.com), a developer, publisher and marketer of independent research products, announced today the release of an updated research report on Sunpeaks Ventures, Inc (OTCBB: SNPK) (“the Company”). Small Cap Investment Research has issued a “STRONG BUY” and a target price of $9.00 on shares of this company.



The report examines the potential continued growth of the Company as it continues to gain market share, and examines the outlook for short and long-term investors. “We were pleased to have the opportunity to report on this company and the industry factors that affect it. The report presents a great overview of the Company and its potential for the long-term with a constantly improving industry dynamic.” – Small Cap Investment Research.



Recently, Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS") announced that HDS has signed a Letter of Intent with PharmaLife® for placement of Clotamin® with leading pharmacies in the Russian Federation.



The Letter of Intent outlines the terms and conditions of a proposed transaction that could see Clotamin distributed by several pharmacy and retail chains in the Russian Federation, including product placement with leading wholesalers Imperia-Pharma, the Dr. Stoletov pharmacy chain (414 locations), and other small retail pharmacies associated with Imperia-Pharma. PharmaLife is also expected to secure timely product registration within the Russian Federation for Clotamin distribution and conduct local market research to support a successful product launch.

The entire report can be found on http://www.smallcapinvestmentresearch.com/featured-companies/ .



About Small Cap Investment Research:

Small Cap Investment Research specializes in providing readers with an in-depth analysis of undervalued companies. The company’s role as an independent research analyst firm is to “separate the wheat from the chaff” and help investors receive unbiased, thought-provoking, and quality investment research. SCIR’s philosophy in research is to encapsulate realistic investment ratings, target prices, and forward-looking financial models. The reports contain hard-hitting, meticulously researched facts on companies, their fundamentals, and their industries, validating a company’s prospects and enabling the reader to objectively evaluate the company’s value. The media and savvy investors alike view this model as how investment research needs to be performed devoid of any partiality.



About Sunpeaks Ventures, Inc.:

Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market. HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.



Forward-Looking Statements

Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to risks and uncertainties. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import also identify forward-looking statements. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of Sunpeaks Ventures, Inc. (OTCBB: SNPK) can be found in the filings of Sunpeaks Ventures, Inc. with the U.S. Securities and Exchange Commission.



Release of Liability: Through use of this website viewing or using you agree to hold SCIR, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. We have been compensated six thousand dollars for this SNPK report. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. SCIR encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SCIR makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies.



Indepedent Research Investment
Derrick Brazinski
3104567798
dbrazinski@indedentresearchinvestment.com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.

U.S. appeals court strikes down Florida law in 'Docs vs. Glocks' case
16 Feb 2017 at 3:05pm
The decision, from the 11th U.S. Circuit Court of Appeals in Atlanta, reverses an earlier decision in the so-called "Docs v. Glocks" case by a three-judge panel of that court upholding the law. The Florida attorney general's office and an attorney representing the doctors challenging the law could not immediately be reached for comment. The American Civil Liberties Union of Florida, which filed a friend-of-the-court brief on behalf of a group of medical and child welfare organizations opposing the law, praised the decision.

The Trump presidency on Feb. 16 at 5:00 p.m. EST
16 Feb 2017 at 3:00pm
(Reuters) - Highlights of the day for U.S. President Donald Trump's administration on Thursday: RUSSIA Trump dismisses a growing controversy about ties between his aides and Russia as a "ruse" and a "scam" perpetrated by a hostile news media, and denies that any of his associates had contacts with Moscow before last year's election. SECURITY The Justice Department says Trump will replace his executive order suspending travel from seven Muslim-majority countries "in the near future," according to a court filing. CABINET AND ADMINISTRATION Trump announces his new choice to lead the Department of Labor, former National Labor Relations Board member Alexander Acosta, after his original pick withdrew under congressional pressure.


Trump, Republicans set timeframe for introducing Obamacare replacement
16 Feb 2017 at 2:53pm

By Richard Cowan and David Morgan WASHINGTON (Reuters) - President Donald Trump and Republicans in Congress said on Thursday that they will soon unveil plans to repeal and replace Obamacare, providing a timeframe for a legislative goal they have struggled with for weeks. Republicans, who control the White House, the U.S. House of Representatives and U.S. Senate, have long vowed to repeal the Affordable Care Act but have had difficulty agreeing on a detailed plan for replacing the signature domestic policy of former Democratic President Barack Obama.


Does penis length recover after prostate removal?
16 Feb 2017 at 2:48pm
By Andrew M. Seaman (Reuters Health) - After prostate removal for cancer, men sometimes complain to their doctors that their penis shrank, but a new study from Japan suggests they should not lose hope. Penis lengths generally returned to normal after one year, however. The study's lead author said the research was started after encountering a few patients complaining of penis shortening after prostate removal, which is known medically as a radical prostatectomy.

New mosquito trap smart enough to keep just the bad bugs
16 Feb 2017 at 2:44pm

A smart trap for mosquitoes? A new high-tech version is promising to catch the bloodsuckers while letting friendlier insects escape ? and even record the exact weather conditions when different species ...



In Trump legislative void, Republicans slow to tackle big issues
16 Feb 2017 at 2:30pm

By Richard Cowan and David Morgan WASHINGTON (Reuters) - President Donald Trump, after nearly a month in power, has yet to unveil major legislation or publicly endorse bills from others, getting Republicans off to a slow start on the sweeping reforms they promised on the campaign trail. As Trump and Republicans ricochet from crisis to crisis, lawmakers have lowered expectations for legislative action in 2017 on tax reform, health care, financial regulation, jobs and infrastructure, with some urging more White House guidance. Ambitious campaign promises by Trump helped the Republicans make a clean sweep of the White House, the Senate and the House of Representatives in November's national elections.


GOP leaders unveil new health law outline, divisions remain
16 Feb 2017 at 2:17pm

Top House Republicans unveiled a rough sketch of a massive health care overhaul to rank-and-file lawmakers Thursday, but a lack of detail, cost estimates and GOP unity left unresolved the problem that's ...



Federal judge dismisses Mass. defamation lawsuit against Cosby
16 Feb 2017 at 2:04pm

A federal judge in Massachusetts on Thursday dismissed a defamation lawsuit against Bill Cosby by an actress who claimed he raped her, ruling that the comedian acted within his rights when he proclaimed himself innocent of the crime. The civil lawsuit is one of a slew of cases brought against the actor, best known for playing the father in the 1980s television hit "The Cosby Show," by about 50 women who say he sexually assaulted them, often after plying them with drugs and alcohol, in a series of alleged attacks dating back decades. The vast bulk of the claims are too old to be the subject of a criminal prosecution, though Cosby is also awaiting trial in Pennsylvania on charges he sexually assaulted a former basketball coach at his alma mater, Temple University.



Trump health pick says Medicaid needs a major overhaul
16 Feb 2017 at 1:07pm

WASHINGTON (AP) ? President Donald Trump's pick to run the government's major health insurance programs said Thursday that Medicaid needs a full overhaul but she doesn't support turning Medicare into a "voucher" plan.



Trump's pick to lead health agency calls EpiPen issue 'disturbing'
16 Feb 2017 at 1:07pm

By Susan Cornwell WASHINGTON (Reuters) - U.S. President Donald Trump's choice to lead an important health agency said on Thursday that the way pharmaceutical companies classify products as generic or branded needs to be reviewed in order to help hold down government spending, as she cited Mylan NV's EpiPen emergency allergy treatment. Seema Verma, Trump's nominee to lead the Centers for Medicare and Medicaid Services (CMS), did not answer questions about whether the U.S. government should negotiate with pharmaceutical companies over drug prices. "I think what happened with ... the EpiPen issue is very disturbing," Verma said at her confirmation hearing before the Senate Finance Committee.


Grandma on bed rest delights social media with her stunning paintings
16 Feb 2017 at 12:49pm
?I?ve been busy,? she proudly told ABC News.

More U.S. seniors taking multiple mind-altering drugs
16 Feb 2017 at 12:13pm
By Lisa Rapaport (Reuters Health) - The number of older adults taking at least three prescriptions for psychotropic drugs - which includes opioids, antidepressants, antipsychotics and tranquilizers - has roughly doubled over the past decade, a recent U.S. study suggests. Nationwide, the number of annual doctor visits involving patients 65 and older who started or were already taking at least three psychotropic drugs surged from 1.5 million in 2004 to 3.68 million in 2013, the study estimated. "This is not among patients with diagnoses like depression, anxiety, or insomnia, but rather in patients with pain and in patients with no mental health or pain diagnosis," noted lead study author Dr. Donovan Maust of the University of Michigan in Ann Arbor.


US flu vaccine a good match; season moderate so far
16 Feb 2017 at 11:42am

NEW YORK (AP) ? This season's flu vaccine seems to be working pretty well, weakening the punch of a nasty bug that's going around, U.S. health officials said Thursday.



Trump says he'll submit healthcare reforms in early or mid-March
16 Feb 2017 at 11:42am

WASHINGTON (Reuters) - President Donald Trump said on Thursday he would be submitting planned reforms to the Affordable Care Act in early March or mid-March.


Spanish woman gives birth to healthy twins at age 64
16 Feb 2017 at 11:39am
MADRID (AP) ? A doctor in northern Spain says a 64-year-old woman has given birth to healthy twins following her second successful pregnancy at an advanced age.

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC